Skip to main content
Clinical Trials/NL-OMON23911
NL-OMON23911Not yet recruitingNot Applicable

Advanced respiratory muscle ultrasound in health and congenital myopathy/muscular dystrophy

Radboudumc0 sites122 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Radboudumc
Enrollment
122

Study Overview

Brief Summary

ot applicable

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • Informed consent from participant or legal representative
  • oPhase 1: age between 18 and 60 years
  • oPhase 2: age between 8 and 60 years
  • -Healthy subjects: competent volunteers
  • -Patients: genetically confirmed congenital myopathy or congenital muscular dystrophy
  • -Willingness and ability to understand nature and content of the study
  • -Ability to participate and comply with study requirements

Exclusion Criteria

  • -Medical history or current condition affecting respiratory muscle strength or function, other than a congenital myopathy or congenital muscular dystrophy (e.g. COPD).
  • -Active smoker
  • -Known upper airway / oesophageal pathology or anatomical variations of the upper airway (phase 1, healthy subjects only)
  • -Known bleeding disorders or frequent nasal bleeding (phase 1, healthy subjects only).

Investigators

Sponsor
Radboudumc

Similar Trials